Breast cancer cells exhibit high surface expression of heparan sulfate (HS) and chondroitin sulfate glycosaminoglycan (CSG), which act as endogenous ligands to specifically activate Toll-like receptor 4 (TLR4) on TANs. This evidence concerns the gene TLR4 and breast carcinoma.